iSpeak Blog
The COVID-19 pandemic has significantly disrupted the biopharma industry megatrends and the world in ways that could not have been predicted. As a result, it forced world leaders, global economists, innovators, and suppliers to collaborate, rethink outdated processes, and innovate together to combat the virus for one common goal, to save human lives. It was by far a pinnacle moment and a great...